Study Treatment for Vitiligo

University of Southern California, Los Angeles, CA
RECELL® Autologous Cell Harvesting DeviceN/ARecruitingResearch Sponsored by Avita Medical

Study Summary

This trial tested using a device to treat vitiligo to see if it improved the skin's colour and quality of life.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 weeks post-treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 weeks post-treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Repigmentation 26-50%, 51-79%, 80-99%, and 100%)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Study TreatmentExperimental Treatment1 Intervention
Skin cell suspension prepared using the RECELL System will be applied to a prepared treatment area, followed by at-home NB-UVB phototherapy.

Find a site

Who is running the clinical trial?

Avita MedicalLead Sponsor
15 Previous Clinical Trials
541 Total Patients Enrolled
4 Trials studying Vitiligo
57 Patients Enrolled for Vitiligo

Media Library

RECELL® Autologous Cell Harvesting Device (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT05971381 — N/A
Vitiligo Research Study Groups: Study Treatment
Vitiligo Clinical Trial 2023: RECELL® Autologous Cell Harvesting Device Highlights & Side Effects. Trial Name: NCT05971381 — N/A
RECELL® Autologous Cell Harvesting Device (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05971381 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the recruitment process currently ongoing for this research project?

"The data on reveals that this medical trial is actively searching for enrollees, with the initial posting date being July 24th 2023 and a recent update made on the 31st of July 2023."

Answered by AI

How many individuals are enrolled in this medical trial?

"Affirmative. The website suggests that the trial, which was originally posted on July 24th 2023, is actively recruiting patients. Approximately 100 individuals must be recruited at one single site to complete the study's objectives."

Answered by AI

Who else is applying?

What state do they live in?
New York
What site did they apply to?
University Medical Center
Mount Sinai
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?

Why did patients apply to this trial?

I would like to find the best affordable treatment. I have non-segmental vitiligo and have done skin grafting previously, I’d like to test the device if I’m eligible too.
~67 spots leftby Jun 2024